Experimental evolution experiments in which bacterial populations are repeatedly exposed
to an antimicrobial treatment, and examination of the genotype and phenotype of the …

Highlights•Some persistent infections are linked to drug resistance and adverse outcomes
such as cancer.•Longitudinal human-infection studies offer access to early and late infection …

Pseudomonas aeruginosa is a common pathogen in cystic fibrosis (CF) patients and a major
contributor to progressive lung damage. P. aeruginosa elastase (LasB), a key virulence …

Mutations in mexZ, encoding a negative regulator of the expression of the mexXY efflux
pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung …

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes high
morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including …

Pseudomonas aeruginosa is an opportunistic pathogen that is responsible for infections in
people living with chronic respiratory conditions, such as cystic fibrosis (CF) and non-CF …

Background Pseudomonas aeruginosa is a multidrug-resistant pathogen causing
recalcitrant pulmonary infections in people with cystic fibrosis (pwCF). Cystic fibrosis …

The ecological and evolutionary mechanisms of antimicrobial resistance (AMR) emergence
within patients and how these vary across bacterial infections are poorly understood …

Pseudomonas aeruginosa is a cause of chronic respiratory tract infections in people with
cystic fibrosis (CF), non-CF bronchiectasis, and chronic obstructive pulmonary disease …

Pseudomonas aeruginosa is included in the ESKAPEE group, which includes pathogens
responsible for nosocomial infections. PgTeL is a lectin from pomegranate sarcotesta active …